A new method for delivering chemotherapy nanodrugs increases the drugs' bioavailability and reduces side-effects.
Administering an FDA-approved nutrition source prior to chemotherapy can reduce the amount of the toxic drugs that settle in the spleen, liver and kidneys.
Chemotherapy Drugs
Chemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body.
Advertisement
‘Administering Intralipid one hour before giving a chemotherapy nano drug reduced the amount of the drug that was found in the liver, spleen and kidneys and reduced the drugs' toxic side-effects.’
Tweet it Now
Nanodrugs, drugs attached to tiny biocompatible particles, show great promise in treatment of a number of diseases, including cancer. Delivery of these drugs, however, is not very efficient -- only about 0.7 percent of chemotherapy nanodrugs reach their target tumor cells.
The remainder are absorbed by other cells, including those in the liver, spleen and kidneys. When the drugs build up in these organs, they cause toxicity and side-effects that negatively impact a patient's quality of life.
![Chemotherapy]( "Chemotherapy")
''Chemo'' means medicine or ''drug'', ''therapy'' means ''treatment''. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.
Chien Ho, professor of biological sciences at Carnegie Mellon University, and his colleagues have developed a novel way to improve delivery of chemotherapy nanodrugs by using Intralipid®, an FDA-approved nutrition source to temporarily blunt the reticuloendothelial system -- a network of cells and tissues found throughout the body, including in the blood, lymph nodes, spleen and liver, that play an important role in the immune system.
Ho and colleagues tested their technique in a rat model of cancer using three FDA-approved chemotherapy nanodrugs, Abraxane®, Marqibo® and Onivyde®, and one experimental platinum-based anti-cancer nanodrug.
In the study, they administered Intralipid one hour before giving the animal a chemotherapy nanodrug. They found that their method reduced the amount of the drug that was found in the liver, spleen and kidneys and reduced the drugs' toxic side-effects. They also found that more of the drug was available to attack tumor cells. Additionally, the Intralipid treatment had no harmful impact on tumor growth or drug efficacy.
The researchers believe that their drug delivery methodology can be applied to a variety of nanodrugs without any modifications to the drugs.
"This methodology could have a major impact in the delivery of nanodrugs not only for patients undergoing chemotherapy for cancer treatment but also to those being treated with nanodrugs for other conditions," said Ho.
Source: Eurekalert
Chemotherapy
''Chemo'' means medicine or ''drug'', ''therapy'' means ''treatment''. Chemotherapy refers to the use of cytotoxic drugs in the treatment of cancer.
Advertisement
Chien Ho, professor of biological sciences at Carnegie Mellon University, and his colleagues have developed a novel way to improve delivery of chemotherapy nanodrugs by using Intralipid®, an FDA-approved nutrition source to temporarily blunt the reticuloendothelial system -- a network of cells and tissues found throughout the body, including in the blood, lymph nodes, spleen and liver, that play an important role in the immune system.
Ho and colleagues tested their technique in a rat model of cancer using three FDA-approved chemotherapy nanodrugs, Abraxane®, Marqibo® and Onivyde®, and one experimental platinum-based anti-cancer nanodrug.
In the study, they administered Intralipid one hour before giving the animal a chemotherapy nanodrug. They found that their method reduced the amount of the drug that was found in the liver, spleen and kidneys and reduced the drugs' toxic side-effects. They also found that more of the drug was available to attack tumor cells. Additionally, the Intralipid treatment had no harmful impact on tumor growth or drug efficacy.
The researchers believe that their drug delivery methodology can be applied to a variety of nanodrugs without any modifications to the drugs.
"This methodology could have a major impact in the delivery of nanodrugs not only for patients undergoing chemotherapy for cancer treatment but also to those being treated with nanodrugs for other conditions," said Ho.
Source: Eurekalert
Fifteen Most Common Chemotherapy Side Effects and Ways to Manage Them
Chemotherapy side effects depend on the chemotherapy treatment as there are varied types of chemotherapy medications. Traditional chemotherapy drugs kill growing cancer cells.
Advertisement
 ToxoplasmosisBrief overview of a common disease called Toxoplasmosis and its risks in human population | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.